These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29477479)

  • 1. Engineered nanomaterial applications in perinatal therapeutics.
    Fournier SB; D'Errico JN; Stapleton PA
    Pharmacol Res; 2018 Apr; 130():36-43. PubMed ID: 29477479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthood.
    Stapleton PA
    J Physiol; 2016 Apr; 594(8):2161-73. PubMed ID: 26332609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply?
    Stapleton PA; Minarchick VC; Yi J; Engels K; McBride CR; Nurkiewicz TR
    Am J Obstet Gynecol; 2013 Sep; 209(3):227.e1-11. PubMed ID: 23643573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome.
    Stapleton PA; Hathaway QA; Nichols CE; Abukabda AB; Pinti MV; Shepherd DL; McBride CR; Yi J; Castranova VC; Hollander JM; Nurkiewicz TR
    Part Fibre Toxicol; 2018 Jan; 15(1):3. PubMed ID: 29321036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantification of gold engineered nanomaterials and impaired fluid transfer across the rat placenta via ex vivo perfusion.
    D'Errico JN; Doherty C; Fournier SB; Renkel N; Kallontzi S; Goedken M; Fabris L; Buckley B; Stapleton PA
    Biomed Pharmacother; 2019 Sep; 117():109148. PubMed ID: 31347503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicines: An approach to treat placental insufficiency and the current challenges.
    van Kammen CM; van Woudenberg SJ; Schiffelers R; Terstappen F; Lely AT
    J Control Release; 2023 Aug; 360():57-68. PubMed ID: 37330012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application of Engineered Nanomaterials in Perinatal Therapeutics.
    Stapleton PA
    Small; 2023 Jul; ():e2303072. PubMed ID: 37438678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antioxidant capacity prevents epitranscriptomic and cardiac alterations in adult offspring gestationally-exposed to ENM.
    Kunovac A; Hathaway QA; Pinti MV; Durr AJ; Taylor AD; Goldsmith WT; Garner KL; Nurkiewicz TR; Hollander JM
    Nanotoxicology; 2021 Aug; 15(6):812-831. PubMed ID: 33969789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.
    Sharma A; Sah N; Kannan S; Kannan RM
    Adv Drug Deliv Rev; 2021 Oct; 177():113950. PubMed ID: 34454979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure.
    Fournier SB; Kallontzi S; Fabris L; Love C; Stapleton PA
    Cardiovasc Toxicol; 2019 Aug; 19(4):321-333. PubMed ID: 30734150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Engineered Nanomaterial Inhalation During Gestation Disrupts Vascular Kisspeptin Reactivity.
    Bowdridge EC; Abukabda AB; Engles KJ; McBride CR; Batchelor TP; Goldsmith WT; Garner KL; Friend S; Nurkiewicz TR
    Toxicol Sci; 2019 Jun; 169(2):524-533. PubMed ID: 30843041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological interactions between nanomaterials and placental development and function following oral exposure.
    Mortensen NP; Johnson LM; Grieger KD; Ambroso JL; Fennell TR
    Reprod Toxicol; 2019 Dec; 90():150-165. PubMed ID: 31476381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta-targeted treatment strategies: An opportunity to impact fetal development and improve offspring health later in life.
    Ganguly E; Hula N; Spaans F; Cooke CM; Davidge ST
    Pharmacol Res; 2020 Jul; 157():104836. PubMed ID: 32344051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The placental exposome: placental determinants of fetal adiposity and postnatal body composition.
    Lewis RM; Demmelmair H; Gaillard R; Godfrey KM; Hauguel-de Mouzon S; Huppertz B; Larque E; Saffery R; Symonds ME; Desoye G
    Ann Nutr Metab; 2013; 63(3):208-15. PubMed ID: 24107818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterial interference with early human placenta: Sophisticated matter meets sophisticated tissues.
    Juch H; Nikitina L; Debbage P; Dohr G; Gauster M
    Reprod Toxicol; 2013 Nov; 41():73-9. PubMed ID: 23751448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental adaptations supporting fetal growth during normal and adverse gestational environments.
    Sferruzzi-Perri AN; Lopez-Tello J; Salazar-Petres E
    Exp Physiol; 2023 Mar; 108(3):371-397. PubMed ID: 36484327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary consequences of gestational toxicant exposure: Symposium overview at the 56th annual SOT meeting, Baltimore, MD.
    Stapleton PA; Wingard CJ; Nurkiewicz TR; Holloway AC; Zelikoff JT; Knudsen TB; Rogers LK
    Reprod Toxicol; 2018 Aug; 79():16-20. PubMed ID: 29709519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver.
    Llewellyn SV; Conway GE; Zanoni I; Jørgensen AK; Shah UK; Seleci DA; Keller JG; Kim JW; Wohlleben W; Jensen KA; Costa A; Jenkins GJS; Clift MJD; Doak SH
    J Nanobiotechnology; 2021 Jun; 19(1):193. PubMed ID: 34183029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.